Study of a Single Dose or Two Doses of a Trivalent Inactivated Influenza Vaccine Produced at Shenzhen, China
Clinical trial NCT02228980 · COMPLETED
Trial details
- NCT number
- NCT02228980
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2014-12-01
- Enrollment
- 602
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.